The Zdenko Kos Foundation funds promising research with a goal to significantly improve the lives of people with cancer's. We welcome applications from academia and industry for support to define, measure and treat Cancer's.
The Objects for which the Foundation is established are the supporting medical researches of all kinds, specially cancer research, support for emerging visual and performing artists and sports talents including water sports for disadvantaged young people in UK and Europe.
We funds studies with sound scientific rationale and clear relevance for people with Cancer's disease (CD).
No idea is too novel for us to consider. We support academic and industry scientists, small biotech’s, big pharma and allied care professionals.
Our portfolio spans basic, translational and clinical research.
We identify projects to fund through multiple channels:
Basic Funding Programs:
Our annual core funding programs are intentionally open-ended, calling for novel and iterative ideas across the spectrum of Cancer's research.
Targeted Funding Programs:
We also issue requests for funding applications or projects that address a specific gap in understanding or patient need.
Supplemental Funding:
We may issue add-on funding if a project shows significant progress and continued potential.
Foundation-driven Initiatives:
Our Foundation sponsors and/or coordinates our own studies.
Grants from The Zdenko Kos Foundation (TZKF or simply TKF) come with more than money.
Successful applicants will/might get access (depend on the project) to a network of advisors: TZKF staff and our many external partners.
You may be invited to join a consortium and/or attend virtual and in-person meetings with others working in the same research area who may enrich or even partner on your project.
Every Foundation got their way for funds. The Zdenko Kos Foundation initiates programmes and assesses funding applications through the lens of three overarching goals:
1. Better Understanding of Oncology Biology
The variability of Cancer's onset and progression and frequent new genetic findings tell us there is much to discover about this disease. Our portfolio ranges from novel discovery to target optimization on the basis DNA to clinical profiling.
2. Translation of Biology to Patient-relevant Therapies
TZKF invests heavily in all aspects of therapeutic development both to directly support individual projects with great potential to help people with all Cancer’s and to provide the field with tools applicable across targets and projects.
3. An Open, Inclusive and Collaborative Research Environment
Robust, collaborative, replicable research leads to faster progress. The Zdenko Kos Foundation works to build an open and collaborative research environment through strategic investment in: